178 related articles for article (PubMed ID: 16326055)
1. Characterization of polymeric dispersions of dimenhydrinate in ethyl cellulose for controlled release.
Desai J; Alexander K; Riga A
Int J Pharm; 2006 Feb; 308(1-2):115-23. PubMed ID: 16326055
[TBL] [Abstract][Full Text] [Related]
2. Drug-polymer interaction and its significance on the physical stability of nifedipine amorphous dispersion in microparticles of an ammonio methacrylate copolymer and ethylcellulose binary blend.
Huang J; Wigent RJ; Schwartz JB
J Pharm Sci; 2008 Jan; 97(1):251-62. PubMed ID: 17724668
[TBL] [Abstract][Full Text] [Related]
3. Preparation and evaluation of solid dispersions of piroxicam and Eudragit S100 by spherical crystallization technique.
Maghsoodi M; Sadeghpoor F
Drug Dev Ind Pharm; 2010 Aug; 36(8):917-25. PubMed ID: 20180658
[TBL] [Abstract][Full Text] [Related]
4. Interplay of formulation and process methodology on the extent of nifedipine molecular dispersion in polymers.
Huang J; Li Y; Wigent RJ; Malick WA; Sandhu HK; Singhal D; Shah NH
Int J Pharm; 2011 Nov; 420(1):59-67. PubMed ID: 21871546
[TBL] [Abstract][Full Text] [Related]
5. An investigation into the effect of spray drying temperature and atomizing conditions on miscibility, physical stability, and performance of naproxen-PVP K 25 solid dispersions.
Paudel A; Loyson Y; Van den Mooter G
J Pharm Sci; 2013 Apr; 102(4):1249-67. PubMed ID: 23359268
[TBL] [Abstract][Full Text] [Related]
6. Physicochemical characterization and drug release studies of nilvadipine solid dispersions using water-insoluble polymer as a carrier.
Hirasawa N; Ishise S; Miyata H; Danjo K
Drug Dev Ind Pharm; 2003 Mar; 29(3):339-44. PubMed ID: 12741614
[TBL] [Abstract][Full Text] [Related]
7. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels.
Zahedi P; Lee PI
Eur J Pharm Biopharm; 2007 Mar; 65(3):320-8. PubMed ID: 17182231
[TBL] [Abstract][Full Text] [Related]
8. Characterization and stability of solid dispersions based on PEG/polymer blends.
Bley H; Fussnegger B; Bodmeier R
Int J Pharm; 2010 May; 390(2):165-73. PubMed ID: 20132875
[TBL] [Abstract][Full Text] [Related]
9. Mid-infrared spectroscopy as a polymer selection tool for formulating amorphous solid dispersions.
Wegiel LA; Mauer LJ; Edgar KJ; Taylor LS
J Pharm Pharmacol; 2014 Feb; 66(2):244-55. PubMed ID: 24433425
[TBL] [Abstract][Full Text] [Related]
10. Stability and solubility enhancement of ellagic acid in cellulose ester solid dispersions.
Li B; Harich K; Wegiel L; Taylor LS; Edgar KJ
Carbohydr Polym; 2013 Feb; 92(2):1443-50. PubMed ID: 23399175
[TBL] [Abstract][Full Text] [Related]
11. Supercritical antisolvent co-precipitation of rifampicin and ethyl cellulose.
Djerafi R; Swanepoel A; Crampon C; Kalombo L; Labuschagne P; Badens E; Masmoudi Y
Eur J Pharm Sci; 2017 May; 102():161-171. PubMed ID: 28302396
[TBL] [Abstract][Full Text] [Related]
12. Investigation of griseofulvin and hydroxypropylmethyl cellulose acetate succinate miscibility in ball milled solid dispersions.
Al-Obaidi H; Lawrence MJ; Al-Saden N; Ke P
Int J Pharm; 2013 Feb; 443(1-2):95-102. PubMed ID: 23299082
[TBL] [Abstract][Full Text] [Related]
13. Physicochemical properties of tadalafil solid dispersions - Impact of polymer on the apparent solubility and dissolution rate of tadalafil.
Wlodarski K; Sawicki W; Haber K; Knapik J; Wojnarowska Z; Paluch M; Lepek P; Hawelek L; Tajber L
Eur J Pharm Biopharm; 2015 Aug; 94():106-15. PubMed ID: 25998701
[TBL] [Abstract][Full Text] [Related]
14. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
[TBL] [Abstract][Full Text] [Related]
15. Undesired co-amorphisation of indomethacin and arginine during combined storage at high humidity conditions.
Petry I; Löbmann K; Grohganz H; Rades T; Leopold CS
Int J Pharm; 2018 Jun; 544(1):172-180. PubMed ID: 29669257
[TBL] [Abstract][Full Text] [Related]
16. Crystal growth formation in melt extrudates.
Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
[TBL] [Abstract][Full Text] [Related]
17. Enhancing dissolution of domperidone by spray-drying: effect of different storage conditions on stability.
Lee JH; Kim MJ; Yang J; Kim KH; Kim HM; Lee SJ; Lee D; Khang G
Ther Deliv; 2014 Mar; 5(3):265-75. PubMed ID: 24592953
[TBL] [Abstract][Full Text] [Related]
18. Preparation and characterization of azithromycin--Aerosil 200 solid dispersions with enhanced physical stability.
Li X; Peng H; Tian B; Gou J; Yao Q; Tao X; He H; Zhang Y; Tang X; Cai C
Int J Pharm; 2015; 486(1-2):175-84. PubMed ID: 25794608
[TBL] [Abstract][Full Text] [Related]
19. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
Fini A; Cavallari C; Ospitali F
Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
[TBL] [Abstract][Full Text] [Related]
20. Formulation optimization of solid dispersion of mosapride hydrochloride.
Kim HJ; Lee SH; Lim EA; Kim JS
Arch Pharm Res; 2011 Sep; 34(9):1467-75. PubMed ID: 21975808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]